The FDA has expanded the approval of Hologicās Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
HealthDay News ā For human papillomavirus (HPV) testing for detection of cervical intraepithelial neoplasia grade 2/3 or worse (CIN2+/CIN3+), minipad-collected menstrual blood shows comparable ...
A study reveals menstrual blood can effectively screen for HPV, matching clinician-collected samples in accuracy, enhancing ...
HPV causes about 36,000 cancer cases each year in the U.S.
Medical Device Network on MSN
Hologicās Aptima assay secures FDA approval for HPV primary screening
With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and ...
New American Cancer Society Guidelines could make it easier for women living in rural areas to get cervical cancer screenings ...
Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...
The American Cancer Society is endorsing the use of self-swab kits to test for HPV, because they may reduce barriers to cervical cancer screening. The amended guidelines will "help improve compliance ...
U.S. guidelines recommend cervical cancer screening every three to five years starting at 21, the CDC says. The American ...
Cancer research turns discovery into better care. At the University of Mississippi Medical Center, research on HPV genotypes has helped change cervical cancer management guidelines, improving patient ...
A recent study out of Norway suggests that female who have received the HPV vaccine may be able to have fewer cervical cancer ...
Cervical cancer screening rates remain low and HPV vaccination rates are also low, despite the FDA approving self-collection as a screening option. Insurance carriers will be required to provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results